Trial · NCT04758728
Adrenaline Reduces Ecchymoses and Hematomas and Improves Quality of Life After Classic Saphenous Vein Stripping
NCT04758728, Not applicable, Completed, Junior Doctors Network-Hellas
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Adrenaline Reduces Ecchymoses and Hematomas and Improves Quality of Life After Classic Saphenous Vein Stripping. Trials, record NCT04758728. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04758728
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Adrenaline Reduces Ecchymoses and Hematomas and Improves Quality of Life After Classic Saphenous Vein Stripping
- NCT number
- NCT04758728
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 40 participants, actual
- Lead sponsor
- Junior Doctors Network-Hellas
- Conditions
- Venous Insufficiency (Chronic)(Peripheral), Venous Reflux, Venous Insufficiency of Leg, Venous Stasis, Venous Disease, Subcutaneous Haematoma, Ecchymosis, Bruising
- Interventions
- Great saphenous vein stripping and varicectomies, Epinephrine Topical, normal saline
- First posted
- 2021-02-17
- Last updated
- 2021-02-18
Source ClinicalTrials.gov
Registered outcomes34
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Subcutaneous ecchymoses number 1d-postop | 24 hours post-operatively | The absolute number of subcutaneous ecchymoses on the operated limb on 1st post-operative day |
| Primary | Subcutaneous ecchymoses number 8d-post-op | 192 hours post-operatively | The absolute number of subcutaneous ecchymoses on the operated limb on 8th post-operative day |
| Primary | Subcutaneous ecchymoses number 14d-post-op | 336 hours post-operatively | The absolute number of subcutaneous ecchymoses on the operated limb on 14th post-operative day |
| Primary | Subcutaneous hematomas number 1d-postop | 24 hours post-operatively | The absolute number of subcutaneous hematomas in the operated limb on 1st post-operative day |
| Primary | Subcutaneous hematomas number 8d-postop | 192 hours post-operatively | The absolute number of subcutaneous hematomas in the operated limb on 8th post-operative day |
| Primary | Subcutaneous hematomas number 14d-postop | 336 hours post-operatively | The absolute number of subcutaneous hematomas in the operated limb on 14th post-operative day |
| Primary | Subcutaneous ecchymoses total area 1d-postop | 24 hours post-operatively | The total area in mm2 of subcutaneous ecchymoses in the operated limb on 1st post-operative day |
| Primary | Subcutaneous ecchymoses total area 8d-postop | 192 hours post-operatively | The total area in mm2 of subcutaneous ecchymoses in the operated limb on 8th post-operative day |
| Primary | Subcutaneous ecchymoses total area 14d-postop | 336 hours post-operatively | The total area in mm2 of subcutaneous ecchymoses in the operated limb on 14th post-operative day |
| Primary | Subcutaneous hematomas total area 1d-postop | 24 hours post-operatively | The total area in mm2 of subcutaneous hematomas in the operated limb on 1st post-operative day |
1 to 10 of 34Source ClinicalTrials.gov
See all 34 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04758728
GET https://conductscience.org/api/trials/v1/NCT04758728/registered?page=2